Science Friday

Covering the outer reaches of space to the tiniest microbes in our bodies, Science Friday is the source for entertaining and educational stories about science, technology, and other cool stuff.

  1. Promising new treatments for pancreatic cancer and ALS

    15 hr ago

    Promising new treatments for pancreatic cancer and ALS

    Pancreatic cancer is among the most deadly forms of cancer, and it can be difficult to catch early. But there’s some good news: Clinical trials of a new drug called daraxonrasib found that it doubled the survival time of patients with advanced pancreatic cancer. And some oncologists are calling it a game changer—not just for pancreatic cancer, but potentially other forms of cancer too. Ira talks with oncologist Zev Wainberg, who led a clinical trial for the drug.  Plus, ALS is a degenerative disease that causes patients to lose their ability to walk, swallow and eventually to breathe. Now, there’s a drug for a rare genetic form of ALS that can slow the progression or even reverse some of these symptoms. Ira talks with New York Times health and science reporter Pam Belluck about this new treatment. Guests: Dr. Zev Wainberg is a co-director of UCLA Health’s GI Oncology Program. Pam Belluck is a health and science reporter for The New York Times. Other episodes you may enjoy: mRNA Vaccine For Pancreatic Cancer Continues To Show Promise How do clinical trials work, and who can participate? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    19 min
  2. Under proposed rule, science funding must pass political review

    2 days ago

    Under proposed rule, science funding must pass political review

    The federal Office of Management and Budget (OMB) has proposed rule changes that would bring a major shift in how scientific grants are awarded by U.S. government agencies. Under the current process, researchers submit grant proposals that are then vetted and scored by a committee of experts in that scientific field, with top-scoring proposals recommended for funding. If its proposed changes are enacted, the OMB would insert a political review into the process, allowing administration officials to determine whether grant proposals are aligned with administration priorities, regardless of their scientific merit. Those proposed rules are now in a public comment period. Holden Thorp, editor in chief of the Science family of journals, joins Ira to explain why he called the change “another red alert for American science” in a recent editorial. Guest: Dr. Holden Thorp is editor in chief of the Science family of journals, at the American Association for the Advancement of Science. Other episodes you may enjoy: A Science Historian Tackles Ghostwriting In Scientific PapersWhat Do mRNA Funding Cuts Mean For Future US Research? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    13 min

About

Covering the outer reaches of space to the tiniest microbes in our bodies, Science Friday is the source for entertaining and educational stories about science, technology, and other cool stuff.

More From WNYC

You Might Also Like